Mode
Text Size
Log in / Sign up
Phase 4 N=64 Randomized Single-blind Treatment

Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.

Pulpitis - Irreversible

Enrolled (actual)
64
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Clinical Success at 6 Months — 27; 30 Participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Pro Root MTA® (Drug); EBRRM® (Drug)
Age
Pediatric, Adult · 10+ yrs
Sex
All
Sponsor
Liaquat University of Medical & Health Sciences
Primary completion
May 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinical Success at 6 Months
27; 30
SECONDARY
Radiographic Success
30; 32

Summary

Although many pulpotomy agents are commercially available, there is a dearth of clinical research comparing the efficacy of these agents in treating individuals with irreversible pulpitis. Bioceramic and MTA both have similar clinical uses, but Bioceramic is distinguished from MTA by its superior chemical, physical, and biological properties. This study aims to address this knowledge deficit by assessing the performance of biocompatible materials in pulpotomy procedures for the treatment of symptomatic permanent teeth in adults with deep caries. For permanent teeth with a completed root and a diagnosis of irreversible pulpitis without apical periodontitis, this research will compare the success rates of MTA and EBRRM pulpotomy procedures in order to provide evidence-based clinical practice guidelines for the treatment of this disease.

Eligibility Criteria

Inclusion Criteria

  • Patients with diagnosis of irreversible pulpitis without apical periodontitis
  • Either gender
  • Lower Age 10 Years - Upper Age 40 Years

Exclusion Criteria

  • Teeth displaying indications of resorption.
  • Teeth that have not fully developed, characterized by open apices.
  • Canals that are calcified or obstructed.
  • Perforations that were caused by the dentist.
  • Fractures in the root
  • Teeth that cannot be restored
  • • Teeth that are unable to withstand frigid temperatures, have a sinus infection, or have swelling around them.
  • There has been no pulp exposure despite the removal of carious lesion.
  • Ten minutes after a pulpotomy, hemorrhage could not be stopped.
  • Necrotic or partly necrotic pulp is indicated by insufficient bleeding after exposure.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05853185). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search